Align Technology, Inc. (NASDAQ:ALGN), the maker of Invisalign clear aligners, saw its stock soar 5.09% in pre-market trading on Monday. This significant uptick comes amid growing interest from billionaire investors and positive company fundamentals, despite the broader market volatility caused by recent U.S. trade policies.

The surge in Align Technology's stock price aligns with recent reports highlighting the company as one of the best high-risk stocks favored by billionaire investors. According to the latest data, ten billionaire investors hold stakes worth $0.71 billion in ALGN, signaling strong confidence in the company's potential. This backing from high-profile investors may be contributing to the stock's positive momentum.

Align Technology's recent performance supports this optimism. The company reported a 4% year-over-year increase in Q4 revenue, reaching $995 million, driven by strong growth in its systems and services segment. Additionally, ALGN has achieved significant milestones, including a record 272,000 active Invisalign-trained practitioners and 19.5 million treated patients. The successful launch of the iTero Lumina scanner and plans to expand into restorative workflows have also garnered positive market responses.

While ALGN is considered a high-risk stock with a beta of 1.68, indicating higher volatility compared to the overall market, its fundamentals remain strong. The company has demonstrated historical profitability and projects a 10.10% EPS growth over the next five years. This combination of billionaire backing, strong fundamentals, and future growth potential appears to be driving investor interest, contributing to today's pre-market surge.